Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteoporosis 3Polycystic Ovary Syndrome 2Obesity 2Neoplasm Metastasis 2Lymphoma 2Leukemia 2Bone Diseases, Metabolic 2Vitamin D Deficiency 1Sexual Dysfunction, Physiological 1Psoriasis 1Pain 1Osteoarthritis 1Neoplasms 1Multiple Myeloma 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Insulin Resistance 1Inflammation 1Hypertension 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1

Interventions

Zoledronic Acid 3saracatinib 1odanacatib 1etelcalcetide hydrochloride 1Vitamin D 1Standard of Care 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bone Diseases × Vitamin D × Clear all
NCT00904423 2017-02-14

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Stanford University

Phase 1/2 Terminated
8 enrolled 4 charts
Breast

Bone Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡